Functional markers including HLA-DR, CD64, CD69, and PD-1 would offer additional insight into cellular activation and exhaustion states, which are increasingly recognized as relevant to the pathophysiology and prognosis of MDD (Grosse et al., 2016a,b; Strawbridge et al., 2015). The gene discussed is FCGR1A; the disease is major depressive disorder.